These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 27348280)

  • 21. Factors associated with comprehensive medication review completion rates: A national survey of community pharmacists.
    Snyder ME; Jaynes HA; Gernant SA; Lantaff WM; Doucette WR; Hudmon KS; Perkins SM
    Res Social Adm Pharm; 2020 May; 16(5):673-680. PubMed ID: 31439525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Economic assessment of changes to an existing medication therapy management program of a large regional health plan.
    Peasah SK; Hammonds T; Liu Y; Campbell V; Manolis C; Good CB
    J Manag Care Spec Pharm; 2021 Feb; 27(2):147-156. PubMed ID: 33506728
    [No Abstract]   [Full Text] [Related]  

  • 23. Online Provision of Part D Medication Therapy Management Program Information.
    Tong Z; Cooke CE; Brandt NJ
    J Manag Care Spec Pharm; 2019 Aug; 25(8):898-903. PubMed ID: 31347982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of Eligibility Criteria Used to Identify Patients for Medication Therapy Management Services: A Retrospective Cohort Study in a Medicare Advantage Part D Population.
    Lee JS; Yang J; Stockl KM; Lew H; Solow BK
    J Manag Care Spec Pharm; 2016 Jan; 22(1):22-30. PubMed ID: 27015048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of comprehensive medication reviews versus noncomprehensive medication review interventions and subsequent successful medication changes in a Medicare Part D population.
    Chinthammit C; Armstrong EP; Boesen K; Martin R; Taylor AM; Warholak T
    J Manag Care Spec Pharm; 2015 May; 21(5):381-9. PubMed ID: 25942999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential Health Implications of Medication Therapy Management Eligibility Criteria in the Patient Protection and Affordable Care Act Across Racial and Ethnic Groups.
    Wang J; Qiao Y; Shih YC; Jarrett-Jamison J; Spivey CA; Wan JY; White-Means SI; Dagogo-Jack S; Cushman WC; Chisholm-Burns M
    J Manag Care Spec Pharm; 2015 Nov; 21(11):993-1003. PubMed ID: 26521111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Pharmacist-Led, Patient-Centered Program Incorporating Motivational Interviewing for Behavior Change to Improve Adherence Rates and Star Ratings in a Medicare Plan.
    Spears J; Erkens J; Misquitta C; Cutler T; Stebbins M
    J Manag Care Spec Pharm; 2020 Jan; 26(1):35-41. PubMed ID: 31880222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive medication review service by embedded pharmacists in primary care: Innovations and impact.
    Yoo A; Fennelly JE; Renauer MM; Coe AB; Choe HM; Marshall VD; Parsons D; Farris KB
    J Am Pharm Assoc (2003); 2022; 62(2):580-587.e1. PubMed ID: 34696978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nationwide estimates of medication therapy management delivery under the Medicare prescription drug benefit.
    Pestka DL; Zillich AJ; Coe AB; Farris KB; Adeoye OA; Snyder ME; Farley JF
    J Am Pharm Assoc (2003); 2020; 60(3):456-461. PubMed ID: 31926872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Environmental Factors on Differences in Quality of Medication Use: An Insight for the Medicare Star Rating System.
    Desai V; Nau D; Conklin M; Heaton PC
    J Manag Care Spec Pharm; 2016 Jul; 22(7):779-86. PubMed ID: 27348278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medicare Medication Therapy Management: beneficiary characteristics and utilization patterns in a national CMS Medicare fee-for-service sample (2013-2016).
    Oyarzún-González X; Abner EL; Freeman P; Kucharska-Newton A; Fardo DW; Moga DC
    J Am Pharm Assoc (2003); 2024 May; ():102140. PubMed ID: 38825153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A checklist for a consistent, comprehensive medication review.
    Vaffis S; Dhatt H; Anderson E; Le D; Campbell PJ; Nelson M; Black H; Kolobova I; Axon DR; Warholak T
    J Am Pharm Assoc (2003); 2023; 63(5):1504-1507.e1. PubMed ID: 37394060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Findings from a National Survey of Medicare Beneficiary Perspectives on the Medicare Part D Medication Therapy Management Standardized Format.
    Brandt NJ; Cooke CE; Sharma K; Chou J; Carden MJ; Kumbera P; Pellegrin K
    J Manag Care Spec Pharm; 2019 Mar; 25(3):366-391. PubMed ID: 30816816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is the Currently Used Prescription Adjudication Date a Good Proxy for Calculating Medication Refill Adherence?
    Lester CA; Look KA; Chui MA
    J Manag Care Spec Pharm; 2016 Nov; 22(11):1311-1317. PubMed ID: 27783554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of prescriber responses to pharmacist recommendations communicated by fax in a medication therapy management program (MTMP).
    Perera PN; Guy MC; Sweaney AM; Boesen KP
    J Manag Care Pharm; 2011 Jun; 17(5):345-54. PubMed ID: 21657804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stimulating comprehensive medication reviews among Medicare Part D beneficiaries.
    Doucette WR; Pendergast JF; Zhang Y; Brown G; Chrischilles EA; Farris KB; Frank J
    Am J Manag Care; 2015 Jun; 21(6):e372-8. PubMed ID: 26247578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Key informant perspectives about telephonic comprehensive medication review services in the United States.
    Anderson EJ; Dhatt H; Vaffis S; Nelson ML; Warholak T; Campbell PJ; Black H; Kolobova I; Axon DR
    J Am Pharm Assoc (2003); 2022; 62(3):817-825.e1. PubMed ID: 35067476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patterns and predictors of older adult Medicare Part D beneficiaries' receipt of medication therapy management.
    Coe AB; Adeoye-Olatunde OA; Pestka DL; Snyder ME; Zillich AJ; Farris KB; Farley JF
    Res Social Adm Pharm; 2020 Sep; 16(9):1208-1214. PubMed ID: 31859225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Medicare Advantage Prescription Drug Plan Star Ratings on Enrollment before and after Implementation of Quality-Related Bonus Payments in 2012.
    Li P; Doshi JA
    PLoS One; 2016; 11(5):e0154357. PubMed ID: 27149092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evolution of the Medicare Part D Medication Therapy Management Program from Inception in 2006 to the Present.
    Gray C; Cooke CE; Brandt N
    Am Health Drug Benefits; 2019 Sep; 12(5):243-251. PubMed ID: 32015791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.